RECRUITINGOBSERVATIONAL
Prevalence of Amyloidosis in Trauma Patients
Prevalence of Amyloidosis in Trauma Patients Using Red Flags Tool
About This Trial
This study aims to determine the frequency of amyloidosis among patients undergoing trauma surgery.
Who May Be Eligible (Plain English)
Who May Qualify:
- Men and women included in the waiting list for scheduled trauma surgery with at least one of the following criteria defined as red flags: Over 65 years old; Possible family history of amyloidosis, Cardiac pathology: aortic stenosis, presence of left ventricular hypertrophy defined as interventricular septal thickness \> 12mm measured by echocardiography, history of previous brady- or tachyarrhythmias including cardiac conduction blocks, history of syncope or presyncope, pro BNP \> 300 in previous blood tests; History of sensory peripheral neuropathy; History of nephropathy without etiological diagnosis; History of liver disease without a clear cause.
- Ability to cooperate in the necessary evaluations.
- Signed willing to sign a consent form for inclusion in the study, either by the participant or their legal representative.
Who Should NOT Join This Trial:
\- Participants previously diagnosed with amyloidosis cannot be included in the study.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Men and women included in the waiting list for scheduled trauma surgery with at least one of the following criteria defined as red flags: Over 65 years old; Possible family history of amyloidosis, Cardiac pathology: aortic stenosis, presence of left ventricular hypertrophy defined as interventricular septal thickness \> 12mm measured by echocardiography, history of previous brady- or tachyarrhythmias including cardiac conduction blocks, history of syncope or presyncope, pro BNP \> 300 in previous blood tests; History of sensory peripheral neuropathy; History of nephropathy without etiological diagnosis; History of liver disease without a clear cause.
* Ability to cooperate in the necessary evaluations.
* Signed informed consent for inclusion in the study, either by the participant or their legal representative.
Exclusion Criteria:
\- Participants previously diagnosed with amyloidosis cannot be included in the study.
Treatments Being Tested
PROCEDURE
Traumatologic surgery
Patients undergoing trauma surgery
Locations (1)
Consorci Sanitari Alt Penedes i Garraf-Hospital Sant Camil
Sant Pere de Ribes, Barcelona, Spain